Chairman, CEO, & Founder, Alexandria Real Estate Equities
CEO and Co-Founder, Tamr
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and CEO of Brooks Bell Inc.
How hard is it to detect and analyze individual circulating tumor cells? Find out what’s next in cancer diagnostics and why such work has the potential to revolutionize how cancer is diagnosed and treated. Invited speakers are Peter Kuhn, a professor at the Scripps Research Institute, and Thomas Broudy, chief scientific officer at Molecular Response. Event is free, but please register online here.